Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note released on Sunday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE opened at $0.00 on Friday. The company has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.05. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.99.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.